Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States
Catherine A. Koss, Sybil Hosek, Peter Bacchetti, et al.
Clinical Infectious Diseases (2017) Vol. 66, Iss. 2, pp. 213-219
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study
Catherine A. Koss, Edwin D. Charlebois, James Ayieko, et al.
The Lancet HIV (2020) Vol. 7, Iss. 4, pp. e249-e261
Open Access | Times Cited: 128
Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions
Matthew A. Spinelli, Jessica E. Haberer, Peter R. Chai, et al.
Current HIV/AIDS Reports (2020) Vol. 17, Iss. 4, pp. 301-314
Open Access | Times Cited: 117
HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda
Catherine A. Koss, Diane V. Havlir, James Ayieko, et al.
PLoS Medicine (2021) Vol. 18, Iss. 2, pp. e1003492-e1003492
Open Access | Times Cited: 62
Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care Test
Monica Gandhi, Peter Bacchetti, Matthew A. Spinelli, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2019) Vol. 81, Iss. 1, pp. 72-77
Open Access | Times Cited: 72
Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers
Beena Thomas, J Vignesh Kumar, Murugesan Periyasamy, et al.
Journal of Medical Internet Research (2021) Vol. 23, Iss. 6, pp. e23294-e23294
Open Access | Times Cited: 55
A Systematic Review of Implementation Research on Determinants and Strategies of Effective HIV Interventions for Men Who Have Sex with Men in the United States
Brian Mustanski, Artur Acelino Francisco Luz Nunes Queiroz, James L. Merle, et al.
Annual Review of Psychology (2023) Vol. 75, Iss. 1, pp. 55-85
Open Access | Times Cited: 18
Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value
Andrew Abaasa, Craig W. Hendrix, Monica Gandhi, et al.
AIDS and Behavior (2017) Vol. 22, Iss. 4, pp. 1165-1173
Open Access | Times Cited: 59
Efficacy of an Empowerment-Based, Group-Delivered HIV Prevention Intervention for Young Transgender Women
Robert Garofalo, Lisa M. Kuhns, Sari L. Reisner, et al.
JAMA Pediatrics (2018) Vol. 172, Iss. 10, pp. 916-916
Open Access | Times Cited: 59
Smartphone-Based Contingency Management Intervention to Improve Pre-Exposure Prophylaxis Adherence: Pilot Trial
John T. Mitchell, Sara LeGrand, Lisa Hightow‐Weidman, et al.
JMIR mhealth and uhealth (2018) Vol. 6, Iss. 9, pp. e10456-e10456
Open Access | Times Cited: 56
Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen
Monica Gandhi, Pamela M. Murnane, Peter Bacchetti, et al.
AIDS (2017) Vol. 31, Iss. 16, pp. 2245-2251
Open Access | Times Cited: 54
Evaluation of the Accuracy of 99DOTS, a Novel Cellphone-based Strategy for Monitoring Adherence to Tuberculosis Medications: Comparison of DigitalAdherence Data With Urine Isoniazid Testing
Beena Thomas, J Vignesh Kumar, M Chiranjeevi, et al.
Clinical Infectious Diseases (2020) Vol. 71, Iss. 9, pp. e513-e516
Open Access | Times Cited: 50
HIV Preexposure Prophylaxis Among Adolescents in the US
Hasiya Yusuf, Errol L. Fields, Renata Arrington‐Sanders, et al.
JAMA Pediatrics (2020) Vol. 174, Iss. 11, pp. 1102-1102
Closed Access | Times Cited: 43
DOT Diary: Developing a Novel Mobile App Using Artificial Intelligence and an Electronic Sexual Diary to Measure and Support PrEP Adherence Among Young Men Who Have Sex with Men
Albert Liu, Nicole Laborde, Kenneth Coleman, et al.
AIDS and Behavior (2020) Vol. 25, Iss. 4, pp. 1001-1012
Open Access | Times Cited: 41
Low tenofovir level in urine by a novel immunoassay is associated with seroconversion in a preexposure prophylaxis demonstration project
Matthew A. Spinelli, David V. Glidden, Warren C. Rodrigues, et al.
AIDS (2019) Vol. 33, Iss. 5, pp. 867-872
Open Access | Times Cited: 39
Real-Time Monitoring and Point-of-Care Testing: A Review of the Current Landscape of PrEP Adherence Monitoring
Alisse Hannaford, Yotam Arens, Helen Koenig
Patient Preference and Adherence (2021) Vol. Volume 15, pp. 259-269
Open Access | Times Cited: 30
Urine Tenofovir Concentrations Correlate With Plasma and Relate to Tenofovir Disoproxil Fumarate Adherence: A Randomized, Directly Observed Pharmacokinetic Trial (TARGET Study)
Paul K. Drain, Rachel W. Kubiak, Oraphan Siriprakaisil, et al.
Clinical Infectious Diseases (2019) Vol. 70, Iss. 10, pp. 2143-2151
Open Access | Times Cited: 32
Adherence to Pre-Exposure Prophylaxis in Adolescents and Young Adults: A Systematic Review and Meta-Analysis
Bianca A. Allison, Laura Widman, Jennifer Stewart, et al.
Journal of Adolescent Health (2021) Vol. 70, Iss. 1, pp. 28-41
Closed Access | Times Cited: 27
A randomised controlled trial to evaluate a medication monitoring system for TB treatment
Joshi Acosta, Paula Vanessa Peclat Flores, MD López Alarcón, et al.
The International Journal of Tuberculosis and Lung Disease (2021) Vol. 26, Iss. 1, pp. 44-49
Open Access | Times Cited: 26
Promises and challenges: cabotegravir for preexposure prophylaxis
Matthew A. Spinelli, Beatriz Grinsztejn, Raphael J. Landovitz
Current Opinion in HIV and AIDS (2022) Vol. 17, Iss. 4, pp. 186-191
Open Access | Times Cited: 18
Performance of a whole blood immunoassay for tenofovir detection and correlation with self‐reported pre‐exposure prophylaxis use in HIV‐negative men who have sex with men interested in blood donation
Renata Buccheri, Barbee I. Whitaker, Lance M. Pollack, et al.
Transfusion (2025)
Closed Access
Pre-exposure prophylaxis engagement among sexual minority men in Taiwan: a behavioral health perspective
Daniel Mayo, Po-Yao Huang
Journal of Behavioral Medicine (2025)
Closed Access
Potential Impact of HIV Preexposure Prophylaxis Among Black and White Adolescent Sexual Minority Males
Deven T. Hamilton, Steven M. Goodreau, Samuel M. Jenness, et al.
American Journal of Public Health (2018) Vol. 108, Iss. S4, pp. S284-S291
Open Access | Times Cited: 31
Electronic medication monitor for people with tuberculosis: Implementation experience from thirty counties in China
Ni Wang, Hemant Deepak Shewade, Pruthu Thekkur, et al.
PLoS ONE (2020) Vol. 15, Iss. 4, pp. e0232337-e0232337
Open Access | Times Cited: 26
Facilitators and barriers of 2-1-1 HIV pre-exposure prophylaxis
Christina Camp, Parya Saberi
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0251917-e0251917
Open Access | Times Cited: 21
Advancing the HIV Pre-Exposure Prophylaxis Continuum: A Collaboration Between a Public Health Department and a Federally Qualified Health Center in the Southern United States
Meredith E. Clement, Barbara Johnston, Cedar Eagle, et al.
AIDS Patient Care and STDs (2019) Vol. 33, Iss. 8, pp. 366-371
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top